Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Surgepays Inc (NASDAQ: SURG) closed at $1.64 down -4.09% from its previous closing price of $1.71. In other words, the price has decreased by -$4.09 from its previous closing price. On the day, 0.14 million shares were traded. SURG stock price reached its highest trading level at $1.701 during the session, while it also had its lowest trading level at $1.61.
Ratios:
For a deeper understanding of Surgepays Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 0.84 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.34. For the most recent quarter (mrq), Quick Ratio is recorded 6.11 and its Current Ratio is at 7.38. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.08.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 01 ’24 when Evers Anthony George sold 8,333 shares for $2.78 per share. The transaction valued at 23,174 led to the insider holds 228,257 shares of the business.
Evers Anthony George sold 83 shares of SURG for $249 on Jul 31 ’24. The Chief Financial Officer now owns 169,923 shares after completing the transaction at $3.00 per share. On Aug 02 ’24, another insider, Cox Kevin Brian, who serves as the CEO and Chairman of Board of the company, sold 33,600 shares for $2.60 each. As a result, the insider received 87,326 and left with 5,737,779 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SURG now has a Market Capitalization of 32381636 and an Enterprise Value of -704312. As of this moment, Surgepays’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.16, and their Forward P/E ratio for the next fiscal year is 13.30. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.29 while its Price-to-Book (P/B) ratio in mrq is 0.69. Its current Enterprise Value per Revenue stands at -0.006 whereas that against EBITDA is 3.045.
Stock Price History:
Over the past 52 weeks, SURG has reached a high of $9.23, while it has fallen to a 52-week low of $1.64. The 50-Day Moving Average of the stock is -39.12%, while the 200-Day Moving Average is calculated to be -65.52%.
Shares Statistics:
For the past three months, SURG has traded an average of 212.72K shares per day and 170140 over the past ten days. A total of 14.40M shares are outstanding, with a floating share count of 13.43M. Insiders hold about 32.00% of the company’s shares, while institutions hold 9.25% stake in the company. Shares short for SURG as of 1723680000 were 540592 with a Short Ratio of 2.54, compared to 1721001600 on 522257. Therefore, it implies a Short% of Shares Outstanding of 540592 and a Short% of Float of 3.8399997999999997.
